证券代码：000877 证券简称：天山股份 公告编号：2025-078 天山材料股份有限公司 关于公开挂牌转让子公司产能指标的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载，误导性陈述或重大遗漏。 因本次交易将以公开挂牌方式进行转让，目前尚无法确定交易对 方。 三、交易标的基本情况 一、交易概述 天山材料股份有限公司（简称"公司"）为最大程度发挥现有产 能价值，结合生产线实际情况，公司所属子公司拟将下属 7 条水泥熟 料生产线的产能指标以公开挂牌方式进行转让（简称"本次交易"）， 拟挂牌的产能指标合计 17,850t/d，折合 535.5 万吨，转让金额合计 约 29,752.65 万元。 2025 年 12 月 12 日公司第九届董事会第十一次会议审议通过了 《关于公开挂牌转让子公司产能指标的议案》，表决结果：9 票同意、 0 票反对、0 票弃权。 鉴于本次交易产生的利润预计累计达到最近一个会计年度经审 计净利润的 10%以上，根据《深圳证券交易所股票上市规则》和《公 司章程》的有关规定，本次交易事项属公司董事会审议决策权限范围 内，无需提交公司股东会审议。 本次交易事项不构 ...

天山材料股份有限公司 关于公开挂牌转让子公司产能指标暨关联交易的公告 证券代码：000877 证券简称：天山股份 公告编号：2025-077 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载，误导性陈述或重大遗漏。 一、关联交易概述 天山材料股份有限公司（简称"公司"）为最大程度发挥现有产 能指标价值，结合生产线实际情况，公司所属子公司 2 条水泥熟料生 产线的产能指标以公开挂牌方式转让（简称"本次交易"），产能指 标合计 4,500t/d，折合 135 万吨，公开挂牌转让金额合计 8,040 万 元。 经产权交易所确认，甘肃祁连山水泥集团有限公司（简称"祁连 山水泥"）的子公司作为唯一意向受让方报名参与并根据挂牌条件缴 纳了保证金，成为本次挂牌的受让方，其拟以挂牌底价受让上述产能 指标。 因公司原高级管理人员王鲁岩担任祁连山水泥董事长，按照《股 票上市规则》的相关规定，其离职后的十二个月内，祁连山水泥及其 所属公司仍为本公司关联法人。本次交易构成关联交易，无关联董事。 本次交易已于 2025 年 12 月 12 日公司第九届董事会第十一次会 议审议通过，无需提交股东会审议批准。 本次 ...

证券代码：000877 证券简称：天山股份 公告编号：2025-076 天山材料股份有限公司 第九届董事会第十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载，误导性陈述或重大遗漏。 一、董事会会议召开情况 1、天山材料股份有限公司(简称"公司")于 2025 年 12 月 10 日 以书面、邮件的方式发出召开第九届董事会第十一次会议的通知。 2、根据《公司章程》，经全体董事同意豁免会议通知时间要求， 公司第九届董事会第十一次会议于 2025 年 12 月 12 日以现场结合视 频方式召开。 3、本次会议应出席董事 9 人，实际出席董事 9 人，董事赵新军、 刘标、范丽婷、满高鹏、薄克刚、沈军、陆正飞、孔伟平、李琛亲自 出席了会议。 4、会议主持人为董事长赵新军，公司部分高级管理人员列席了 本次会议。 5、会议召开符合有关法律、行政法规、部门规章、规范性文件 和公司章程的规定。 二、董事会会议审议情况 （一）审议通过了《关于豁免会议通知时限的议案》 本议案表决情况：9 票同意，0 票反对，0 票弃权。 同意豁免本次董事会临时会议的会议通知时限。 （二）审议通过了《关于 ...

12月11日，天山股份大宗交易成交220万股，成交额1108.8万元，占当日总成交额的15.03%，成交价 5.04元，较市场收盘价5.51元折价8.53%。 | 权益类证券大宗交易(协议交易) | | | | | | 团 下载 | | --- | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券代码 | 证券简称 | 成交价格 (元) | 成交量 (万股/万份) | 成交金额 买方营业部 (万元) | 卖方营业部 | | 2025-12-11 | 000877 | 天山股份 | 5.04 | 220.00 | 1,108.8 国联民生证券股份 | 中国中金财富证券 | | | | | | | 有限公司杭州金城 | 有限公司上海浦东 | | | | | | | 路班券营不出 | 新区陆家嘴环路证 | | | | | | | | #营业部 | ...

证券代码：000877 证券简称：天山股份 公告编号：2025-075 天山材料股份有限公司 2025 年第六次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1.本次股东会未出现否决提案的情形。 2.本次股东会未涉及变更以往股东会已通过的决议。 一、会议召开情况 1、会议日期 1.1 现场会议时间：2025 年 12 月 10 日 14:30 1.2 网络投票时间为：2025 年 12 月 10 日，其中，通过深圳证券 交易所交易系统投票的具体时间为：2025 年 12 月 10 日上午 9:15 至 9:25，9:30 至 11:30，下午 13:00 至 15:00；通过深圳证券交易所互 联网投票的具体时间为：2025 年 12 月 10 日 9:15 至 15:00 的任意时 间。 1.3 会议召集人：公司第九届董事会 1.4 会议主持人：公司董事长赵新军 1.5 现场会议地点：上海市浦东新区世博馆路 70 号中国建材大 厦会议室。 1.6 本次股东会的召开符合《公司法》《上市公司股东会规则》 （简称"《股东会规则》"） ...

北京市嘉源律师事务所 关于天山材料股份有限公司 2025 年第六次临时股东会的 法律意见书 西城区复兴门内大街 158 号远洋大厦 4 楼 中国 · 北京 北京 BEIJING · 上海 SHANGHAI ·深圳 SHENZHEN·香港 HONGKONG·广州 GUANGZHOU·西安 XI AN 致:天山材料股份有限公司 北京市嘉源律师事务所 关于天山材料股份有限公司 2025年第六次临时股东会的法律意见书 嘉源(2025)-04-904 北京市嘉源律师事务所(以下简称"本所")接受天山材料股份有限公司(以 下简称"公司")委托,根据《中华人民共和国公司法》(以下简称"《公司法》")、 《上市公司股东会规则》（以下简称"《股东会规则》"）等现行有效的法律、 行政法规、部门规章、规范性文件(以下简称"法律法规")以及《天山材料股 份有限公司章程》(以下简称"《公司章程》")的有关规定,指派本所律师对 公司 2025年第六次临时股东会(以下简称"本次股东会")进行见证,并依法 出具本法律意见书。 为出具本法律意见书,本所指派律师现场见证了本次股东会,查阅了公司提 供的与本次股东会有关的文件和资料,并进行了必要的 ...

相关报告：智研咨询发布的《2026-2032年中国水泥行业市场运行格局及发展策略分析报告》 上市企业：青松建化（600425）,金隅集团（601992）,四川金顶（600678）,福建水泥（600802）,上峰水 泥（000672）,祁连山（600720）,冀东水泥（000401）,华新水泥（600801）,天山股份（000877）,海螺 水泥（600585） 根据国家统计局数据显示：2025年10月中国水泥产量为1.5亿吨，同比下降15.8%；2025年1-10月中国水 泥累计产量为14亿吨，累计下降6.7%。 数据来源：国家统计局，智研咨询整理 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 2020-2025年1-10月中国水泥产量统计图 ...

Group 1 - Century Huatong plans to change the use of 1.28 million repurchased shares from equity incentive plans to cancellation, reducing total share capital from 7.428 billion to 7.427 billion shares [2] - Wuliangye adjusts its 2025 investment plan, increasing the number of projects from 19 to 22 and changing the investment amount from 2.586 billion to 2.207 billion yuan [3] - Qingyue Technology is under investigation for suspected financial data fraud, with the possibility of forced delisting if found guilty [4] Group 2 - Kang Enbei's chairman and legal representative resigns due to work adjustments, along with another board member [5] - Tianshan Co. expects a tax payment of approximately 61.86 million yuan to impact its 2025 net profit [6] - Muyuan Foods reports a 20.43% year-on-year decline in November sales revenue from live pigs, totaling 9.39 billion yuan [7] Group 3 - GAC Group's November automobile sales decreased by 9.72% year-on-year, with total sales of 1.797 million vehicles [8] - Western Pastoral's fresh milk production in November increased by 6.3% month-on-month but decreased by 6.47% year-on-year [9] - Gemdale Group's November contracted area fell by 58.50% year-on-year, with a total contracted amount of 1.52 billion yuan [10] Group 4 - Zhenghong Technology reports November sales revenue of 4.5196 million yuan from live pigs, with a year-on-year decline of 21.83% [11] - Wens Foodstuff's November chicken sales reached 118 million birds, generating 3.324 billion yuan in revenue [12] - Meilixin's controlling shareholder plans to increase holdings by no less than 50 million yuan [13] Group 5 - Hongcheng Environment's subsidiary wins an 853 million yuan sewage treatment project [14] - Dongzhu Ecology wins a 397 million yuan environmental project [15] - Xindian Software secures a 54 million yuan project for digital community construction [16] Group 6 - China Chemical announces that its nylon new material project has reached full production [17] - Jiaojian Co. is in discussions regarding overdue payments related to financial products, clarifying that it bears no responsibility for these products [18] - Micron Biotech's product is included in the 2025 National Medical Insurance Directory [19] Group 7 - Yitian Intelligent plans to sell 600 smart computing machines for a total of 1.56 billion yuan [20] - First Venture's subsidiary receives an administrative penalty notice from Jiangsu Securities Regulatory Bureau [21] - China Insurance's vice president is under investigation for serious violations [22] Group 8 - Zhixiang Jintai's monoclonal antibody injection is included in the 2025 National Medical Insurance Directory [23] - Haichuang Pharmaceutical's drug is also included in the National Medical Insurance Directory [24] - Yuanli Co. plans to acquire 49% of Clarimex for 25.56 million USD [25] Group 9 - Betta Pharmaceuticals' products are included in the National Medical Insurance Directory [26] - Tianci Materials' controlling shareholder commits to not reducing holdings for six months [27] - Guanglian Aviation's actual controller has had a detention measure lifted [28] Group 10 - Annie Co. announces a share transfer agreement that will make Shengshi Tianan the controlling shareholder [29] - Double Star New Materials notes uncertainty regarding the sustainability of long-term price increases [30] - ST Tianrui terminates plans for a change in control and resumes trading [31] Group 11 - Guao Technology is planning a change in control, leading to a temporary suspension of its stock [32] - Guangqi Technology's subsidiary signs contracts worth 696 million yuan for the production of metamaterials [33] - Shuoshi Biotech's monkeypox virus detection kit is included in the WHO emergency use list [34]

Industry News - The draft of the "Guidelines for Performance Evaluation Management of Fund Management Companies" has been issued, requiring that the weight of long-term investment return indicators for more than three years should not be less than 80% [40] - Fund managers are required to invest at least 40% of their total performance compensation in the public funds they manage, excluding non-equity products [40] - If a fund's performance over the past three years is more than ten percentage points below the benchmark and the fund's profit margin is negative, the performance compensation of the fund manager should decrease significantly compared to the previous year, with a reduction of no less than 30% [40] - The 2025 National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Directory will be released, adding 114 new drugs, including 50 Class 1 innovative drugs [40] - The first version of the Commercial Health Insurance Innovative Drug Directory has also been released, including 19 drugs, such as CAR-T and Alzheimer's treatment drugs, with the new drug directory officially implemented from January 1, 2026 [40] - The National Financial Regulatory Administration has issued a notice to adjust the risk factors related to insurance companies' businesses, lowering risk factors for long-term holdings of stocks in the CSI 300 Index and the Sci-Tech Innovation Board [41] - The adjustment is expected to bring over 100 billion yuan in incremental funds to the stock market if insurance funds fully increase their allocation to corresponding stocks, significantly enhancing market liquidity [41] - Recent reports indicate that the spot price of storage chips has surged, with DDR4x particles increasing by over four times this year, while manufacturers face a tight supply chain with inventory levels below four weeks [41][42] Company News - Baidu has issued a clarification announcement stating that it is evaluating the spin-off of Kunlun Chip for listing, but does not guarantee that the spin-off and listing will proceed [43] - Vanke announced on December 5 that it has decided to give up exercising the redemption option for "21 Vanke 02" [44] - China Pacific Insurance announced that Vice President Yu Ze is under investigation for serious violations of discipline and law [44] - Muxi Co., Ltd. announced that the final winning rate for online issuance after the callback mechanism was 0.03348913% [45] - Guo Ao Technology announced that its actual controller is planning a change of control, and the stock will be suspended from trading starting December 8, with an expected suspension period of no more than two trading days [45] - Annie Co., Ltd. announced that Shengshi Tianan will become its controlling shareholder, with the actual controller changing to Li Ning and Wang Lei, and the stock will resume trading on December 8 [45] - Zhongneng Electric announced plans to acquire equity and debt from three companies, which is expected to constitute a major asset restructuring [46] - Bohai Chemical announced plans to sell 100% of Bohai Petrochemical and acquire control of Taida New Materials, leading to stock suspension [47]

Group 1 - The year-end market is expected to experience rapid rotation, primarily maintaining a volatile structure [1][15][16] - The A-share market has achieved reasonable growth in volume and effective improvement in quality [6] - The Nasdaq China Golden Dragon Index increased by 1.29%, with notable gains from companies like Dingdong Maicai and Baidu [4] Group 2 - The U.S. stock market saw moderate gains, with the Dow Jones up 0.22% and the S&P 500 up 0.19% [4] - Major tech companies showed mixed performance, with Microsoft and Google gaining while Apple declined [4] - The WTI crude oil futures rose by 0.69% to $60.08, marking a weekly increase of 2.61% [4] Group 3 - The State Council is focusing on energy conservation and carbon reduction, along with regulatory measures for administrative law enforcement [6] - The China Securities Regulatory Commission (CSRC) emphasizes the importance of long-term and value investment products [6][8] - The National Financial Supervision Administration has adjusted risk factors for insurance companies, lowering certain risk factors for long-term holdings [7] Group 4 - The Ministry of Commerce is promoting consumer spending and expanding the market for durable goods [10] - The new drug directory for national medical insurance will be implemented starting January 1, 2026, with 114 new drugs added [12] - The online liquor market is projected to grow significantly, with a GMV of approximately 150 billion yuan in 2024 [13]